Epidermal growth factor receptor mRNA (EGFR mRNA)

Epidermal growth factor receptor (EGFR) mRNA is the messenger RNA transcript encoded by the EGFR gene, which serves as the essential template for the synthesis of the EGFR protein, a member of the ErbB family of receptor tyrosine kinases (Source: NCBI Gene ID 1956). The translation of this mRNA results in a transmembrane protein that regulates critical cellular processes including proliferation, differentiation, and survival through the MAPK, PI3K/Akt, and STAT pathways (Source: UniProt P00533). In various malignancies, such as non-small cell lung cancer and glioblastoma, EGFR mRNA is frequently overexpressed or mutated, driving oncogenic signaling and tumor progression (Source: PubMed PMID: 25223563). Therapeutic targeting of the mRNA transcript using antisense oligonucleotides (ASOs) or small interfering RNAs (siRNAs) aims to silence gene expression at the pre-translational level, potentially bypassing resistance mechanisms that affect small molecule inhibitors or monoclonal antibodies (Source: Nature Reviews Drug Discovery, 2017). By degrading the mRNA, these therapies can reduce the total cellular pool of both wild-type and mutant EGFR proteins, offering a comprehensive approach to inhibiting this well-validated oncogenic driver (Source: ClinicalTrials.gov NCT00005851).

Other names

ERBB1 mRNAHER1 mRNAPIG61 mRNAEpidermal growth factor receptor transcriptProto-oncogene c-ErbB-1 mRNA

Antisense inhibition and RNA interference (RNAi) leading to RNase H-mediated cleavage or RISC-mediated degradation of the mRNA transcript, thereby preventing translation into the EGFR protein.